Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCENT: Bevacizumab in metastatic colorectal cancer
NCT01588990Phase 4Completed
- Sponsor
- Roche
- Start
- Jun 2012
- Primary completion
- Sep 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of bevacizumab in metastatic colorectal cancer (mCRC), sponsored by Roche. Started Jun 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01588990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01588990.